Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

Jayani Pathirana, Flor M. Muñoz, Victoria Abbing-Karahagopian, Niranjan Bhat, Tara Harris, Ambujam Kapoor, Daniel L. Keene, Alexandra Mangili, Michael A. Padula, Stephen L. Pande, Vitali Pool, Farshad Pourmalek, Frederick Varricchio, Sonali Kochhar, Clare L. Cutland

Research output: Contribution to journalArticle

Abstract

More than 40% of all deaths in children under 5 years of age occur during the neonatal period: the first month of life. Immunization of pregnant women has proven beneficial to both mother and infant by decreasing morbidity and mortality. With an increasing number of immunization trials being conducted in pregnant women, as well as roll-out of recommended vaccines to pregnant women, there is a need to clarify details of a neonatal death. This manuscript defines levels of certainty of a neonatal death, related to the viability of the neonate, who confirmed the death, and the timing of the death during the neonatal period and in relation to immunization of the mother.

Original languageEnglish (US)
JournalVaccine
DOIs
StateAccepted/In press - 2016
Externally publishedYes

Fingerprint

Pregnant Women
Immunization
immunization
Guidelines
death
Safety
pregnant women
Mothers
Vaccines
Newborn Infant
Morbidity
Mortality
morbidity
neonates
Perinatal Death
viability
vaccines

Keywords

  • Adverse event
  • Case definition
  • Guidelines
  • Maternal immunization
  • Neonatal death

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Pathirana, J., Muñoz, F. M., Abbing-Karahagopian, V., Bhat, N., Harris, T., Kapoor, A., ... Cutland, C. L. (Accepted/In press). Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. https://doi.org/10.1016/j.vaccine.2016.03.040

Neonatal death : Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. / Pathirana, Jayani; Muñoz, Flor M.; Abbing-Karahagopian, Victoria; Bhat, Niranjan; Harris, Tara; Kapoor, Ambujam; Keene, Daniel L.; Mangili, Alexandra; Padula, Michael A.; Pande, Stephen L.; Pool, Vitali; Pourmalek, Farshad; Varricchio, Frederick; Kochhar, Sonali; Cutland, Clare L.

In: Vaccine, 2016.

Research output: Contribution to journalArticle

Pathirana, J, Muñoz, FM, Abbing-Karahagopian, V, Bhat, N, Harris, T, Kapoor, A, Keene, DL, Mangili, A, Padula, MA, Pande, SL, Pool, V, Pourmalek, F, Varricchio, F, Kochhar, S & Cutland, CL 2016, 'Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data', Vaccine. https://doi.org/10.1016/j.vaccine.2016.03.040
Pathirana, Jayani ; Muñoz, Flor M. ; Abbing-Karahagopian, Victoria ; Bhat, Niranjan ; Harris, Tara ; Kapoor, Ambujam ; Keene, Daniel L. ; Mangili, Alexandra ; Padula, Michael A. ; Pande, Stephen L. ; Pool, Vitali ; Pourmalek, Farshad ; Varricchio, Frederick ; Kochhar, Sonali ; Cutland, Clare L. / Neonatal death : Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. In: Vaccine. 2016.
@article{04dc59e71f7c42cdbe7974b8ae12a980,
title = "Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data",
abstract = "More than 40{\%} of all deaths in children under 5 years of age occur during the neonatal period: the first month of life. Immunization of pregnant women has proven beneficial to both mother and infant by decreasing morbidity and mortality. With an increasing number of immunization trials being conducted in pregnant women, as well as roll-out of recommended vaccines to pregnant women, there is a need to clarify details of a neonatal death. This manuscript defines levels of certainty of a neonatal death, related to the viability of the neonate, who confirmed the death, and the timing of the death during the neonatal period and in relation to immunization of the mother.",
keywords = "Adverse event, Case definition, Guidelines, Maternal immunization, Neonatal death",
author = "Jayani Pathirana and Mu{\~n}oz, {Flor M.} and Victoria Abbing-Karahagopian and Niranjan Bhat and Tara Harris and Ambujam Kapoor and Keene, {Daniel L.} and Alexandra Mangili and Padula, {Michael A.} and Pande, {Stephen L.} and Vitali Pool and Farshad Pourmalek and Frederick Varricchio and Sonali Kochhar and Cutland, {Clare L.}",
year = "2016",
doi = "10.1016/j.vaccine.2016.03.040",
language = "English (US)",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Neonatal death

T2 - Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

AU - Pathirana, Jayani

AU - Muñoz, Flor M.

AU - Abbing-Karahagopian, Victoria

AU - Bhat, Niranjan

AU - Harris, Tara

AU - Kapoor, Ambujam

AU - Keene, Daniel L.

AU - Mangili, Alexandra

AU - Padula, Michael A.

AU - Pande, Stephen L.

AU - Pool, Vitali

AU - Pourmalek, Farshad

AU - Varricchio, Frederick

AU - Kochhar, Sonali

AU - Cutland, Clare L.

PY - 2016

Y1 - 2016

N2 - More than 40% of all deaths in children under 5 years of age occur during the neonatal period: the first month of life. Immunization of pregnant women has proven beneficial to both mother and infant by decreasing morbidity and mortality. With an increasing number of immunization trials being conducted in pregnant women, as well as roll-out of recommended vaccines to pregnant women, there is a need to clarify details of a neonatal death. This manuscript defines levels of certainty of a neonatal death, related to the viability of the neonate, who confirmed the death, and the timing of the death during the neonatal period and in relation to immunization of the mother.

AB - More than 40% of all deaths in children under 5 years of age occur during the neonatal period: the first month of life. Immunization of pregnant women has proven beneficial to both mother and infant by decreasing morbidity and mortality. With an increasing number of immunization trials being conducted in pregnant women, as well as roll-out of recommended vaccines to pregnant women, there is a need to clarify details of a neonatal death. This manuscript defines levels of certainty of a neonatal death, related to the viability of the neonate, who confirmed the death, and the timing of the death during the neonatal period and in relation to immunization of the mother.

KW - Adverse event

KW - Case definition

KW - Guidelines

KW - Maternal immunization

KW - Neonatal death

UR - http://www.scopus.com/inward/record.url?scp=84978863588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978863588&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2016.03.040

DO - 10.1016/j.vaccine.2016.03.040

M3 - Article

AN - SCOPUS:84978863588

JO - Vaccine

JF - Vaccine

SN - 0264-410X

ER -